Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

Authors: Ari Green, Jeffrey M. Gelfand, Bruce Cree, Carolyn Bevan, W. John Boscardin, Feng Mei, Justin Inman, Sam Arnow, Michael Devereux, Aya Abounasr, Hiroko Nobuta, Alyssa H. Zhu, Matt Friessen, Roy Gerona, H.‐Christian von Büdingen, Roland G. Henry, Stephen L. Hauser, Jonah R. Chan - The Lancet 2017 cited by 577